Bridging therapy is the important adjuvant therapy for hepatocellular carcinoma before liver transplantation, which can decrease the dropout rate and the recurrence rates after liver transplantation, prolonging tumor free survival and total survival. Bridging therapy has played a more and more important roles in delaying tumor progression for patients waiting for liver transplantation. With the development of technology used for clinical purpose, kinds of bridging therapy have become more mature and perfect. However, some problems still need to be solved. This article aims to analyze the current situation of the development and looking forward to the new technology of bridging therapy, besides, putting forward the proposal to the current problems

• ref